ES2194983T3 - Uso de lactoferrina para la fabricacion de un agente preventivo para astigmatismo postoperatorio. - Google Patents
Uso de lactoferrina para la fabricacion de un agente preventivo para astigmatismo postoperatorio.Info
- Publication number
- ES2194983T3 ES2194983T3 ES96910225T ES96910225T ES2194983T3 ES 2194983 T3 ES2194983 T3 ES 2194983T3 ES 96910225 T ES96910225 T ES 96910225T ES 96910225 T ES96910225 T ES 96910225T ES 2194983 T3 ES2194983 T3 ES 2194983T3
- Authority
- ES
- Spain
- Prior art keywords
- lactoferrine
- postoperative astigmatism
- manufacture
- preventive agent
- astigmatism
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 201000009310 astigmatism Diseases 0.000 title abstract 4
- 230000002980 postoperative effect Effects 0.000 title abstract 4
- 230000003449 preventive effect Effects 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 102000010445 Lactoferrin Human genes 0.000 abstract 1
- 108010063045 Lactoferrin Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 abstract 1
- 229940078795 lactoferrin Drugs 0.000 abstract 1
- 235000021242 lactoferrin Nutrition 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/40—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Surgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Abstract
UN OBJETO DE LA PRESENTE INVENCION ES ENCONTRAR UN FARMACO QUE SEA UTIL PARA LA PREVENCION DEL ASTIGMATISMO POSTOPERATORIO. LA PRESENTE INVENCION PROPORCIONA UN PREVENTIVO PARA EL ASTIGMATISMO POSTOPERATORIO QUE COMPRENDE LACTOFERRINA COMO UN INGREDIENTE ACTIVO. UNA FORMA DE DOSIFICIACION PREFERENTE DEL PREVENTIVO PARA EL ASTIGMATISMO POSTOPERATORIO ES UNA DISOLUCION OFTALMICA, Y UNA CONCENTRACION PREFERENTE DE LACTOFERRINA ES 0,1 A 1,0 % (P/V).
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP07109239A JP3118584B2 (ja) | 1995-05-08 | 1995-05-08 | 術後乱視予防剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2194983T3 true ES2194983T3 (es) | 2003-12-01 |
Family
ID=14505148
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES96910225T Expired - Lifetime ES2194983T3 (es) | 1995-05-08 | 1996-04-23 | Uso de lactoferrina para la fabricacion de un agente preventivo para astigmatismo postoperatorio. |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6645936B1 (es) |
| EP (1) | EP0826373B1 (es) |
| JP (1) | JP3118584B2 (es) |
| AT (1) | ATE241382T1 (es) |
| DE (1) | DE69628430T2 (es) |
| DK (1) | DK0826373T3 (es) |
| ES (1) | ES2194983T3 (es) |
| WO (1) | WO1996035448A1 (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH1149698A (ja) | 1997-07-31 | 1999-02-23 | Santen Pharmaceut Co Ltd | 安定性を向上させたラクトフェリンの水性製剤 |
| EP1284143A1 (en) * | 2001-08-17 | 2003-02-19 | Sifi S.p.A | A process for the preparation of pharmaceutical formulations containing lactoferrin description |
| US20070059300A1 (en) * | 2005-09-12 | 2007-03-15 | Zoltan Laboratories Llc | Compounds and compositions to control abnormal cell growth |
| EP1942928A2 (en) * | 2005-10-31 | 2008-07-16 | Essential Skincare, LLC | Protein composition for promoting wound healing and skin regeneration |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2460135A1 (fr) * | 1979-07-02 | 1981-01-23 | Liotet Serge | Composition a usage externe a base de colostrum |
| JPH0248534A (ja) | 1988-07-28 | 1990-02-19 | Bio Serae Sa:Soc | 抗菌組成物の配合方法及び配合された抗菌組成物 |
| EP0579830B1 (en) * | 1990-11-13 | 1997-02-05 | Santen Pharmaceutical Co., Ltd. | Therapeutic agent for corneal lesion |
| JP3812957B2 (ja) | 1994-08-02 | 2006-08-23 | 森永乳業株式会社 | 角膜損傷治療剤 |
-
1995
- 1995-05-08 JP JP07109239A patent/JP3118584B2/ja not_active Expired - Fee Related
-
1996
- 1996-04-23 WO PCT/JP1996/001092 patent/WO1996035448A1/ja active IP Right Grant
- 1996-04-23 DK DK96910225T patent/DK0826373T3/da active
- 1996-04-23 EP EP96910225A patent/EP0826373B1/en not_active Expired - Lifetime
- 1996-04-23 ES ES96910225T patent/ES2194983T3/es not_active Expired - Lifetime
- 1996-04-23 AT AT96910225T patent/ATE241382T1/de not_active IP Right Cessation
- 1996-04-23 DE DE69628430T patent/DE69628430T2/de not_active Expired - Fee Related
- 1996-04-23 US US08/945,901 patent/US6645936B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE241382T1 (de) | 2003-06-15 |
| DE69628430T2 (de) | 2004-05-19 |
| DK0826373T3 (da) | 2003-09-29 |
| DE69628430D1 (de) | 2003-07-03 |
| EP0826373A4 (en) | 2000-06-14 |
| JPH08301785A (ja) | 1996-11-19 |
| WO1996035448A1 (fr) | 1996-11-14 |
| US6645936B1 (en) | 2003-11-11 |
| JP3118584B2 (ja) | 2000-12-18 |
| EP0826373B1 (en) | 2003-05-28 |
| EP0826373A1 (en) | 1998-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2174920T3 (es) | Producto de combinacion para la contracepcion que contiene agentes antagonistas de progesterona y un agente gestageno. | |
| DK0868909T3 (da) | Opthalmisk bæreropløsning | |
| AR024874A1 (es) | Composiciones bactericidas | |
| ES2098920T3 (es) | Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina. | |
| ES2178048T3 (es) | Uso de rifaximina como medicamento para el tratamiento de diarrea por criptosporidiosis. | |
| RS50768B (sr) | Režim doziranja i farmaceutska formulacija za urgentnu zaštitu | |
| KR100260061B1 (en) | Vitamin e drop | |
| MX9400800A (es) | Un complejo de estabilizacion neutro para ci-979 hci, un activador de la cognicion. | |
| DE60044341D1 (de) | Arzneimittel für gelenkkrankheiten | |
| MX9400801A (es) | Agentes colinergicos de oxima de tetrahidropiridinna o-substituidos estabilizados con almidon. | |
| BRPI0417585A (pt) | composição pregabalina | |
| PL402550A1 (pl) | Dopochwowe kompozycje farmaceutyczne oraz zastosowanie zródla nadtlenku i bioadhezyjnego nosnika | |
| ATE324112T1 (de) | Topische behandlung bei der mastalgie | |
| ES2194983T3 (es) | Uso de lactoferrina para la fabricacion de un agente preventivo para astigmatismo postoperatorio. | |
| ES2125356T3 (es) | Empleo de leflunomida para la inhibicion de interleuquina 8. | |
| TW200503709A (en) | Itching treating agent containing piperidine derivative as active ingredient | |
| ES2147796T3 (es) | Composicion para el tratamiento o la prevencion del herpes. | |
| DE60032246D1 (de) | Zusammensetzungen, welche tetracycline enthalten, zur behandlung oder verhinderung von mukositis | |
| PT862433E (pt) | Composicao farmaceutica espumante topica para o tratamento de dermatoses induzidas por pityrosporum oval | |
| KR950007852A (ko) | 우라실을 유효성분으로 함유하는 관절염 치료제 | |
| AR016200A1 (es) | El uso de una composicion que comprende uno o mas compuestos que contienen azufre para la fabricacion de un medicamento para aumentar la permeabilidad deltejido corneo humano, y un kit que incluye dicha composicion | |
| BR0317292A (pt) | Derivados de amida de ácido antranìlico e seu uso farmacêutico | |
| KR930702016A (ko) | 골다공증 치료제 | |
| EP0992242A4 (en) | PROPHYLACTIC AGENTS AND / OR REMEDIES CONTAINING VITAMIN D FOR PREVENTING AND / OR TREATING CONJUNCTIVAL / CORNEAL XEROSIS | |
| BR0215352A (pt) | Composição farmacêutica que compreende um inibidor de alfa-glicosidase e um ácido 4-oxobutanóico, e seu uso para tratar diabetes |